The bear case on Eli Lilly has played out, says only firm to have called it a sell


The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst said Wednesday in upgrading the stock.Weiter zum vollständigen Artikel bei MarketWatch

Werbung